drugset / Trial / NCT05045053
Efficacy of Xiidra in Dry Eye Disease After Collagen Cross Linking
RandomizedParallel-groupSingle-blindTreatment
Summary
dry eye disease after corneal collagen cross linking affect ocular function leading to reduced vision, photophobia, glare, halos, and foreign body sensation.
Timeline
- Start
- 2021-02-01
- Primary completion
- 2022-01
- Completion
- 2022-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lifitegrast | Unknown | 0.5 % | Other |